The International Society for Pharmaceutical Engineering’s (ISPE) Pharma 4.0 Special Interest Group (SIG) has been working since 2015 to translate how Industry 4.0 impacts pharmaceutical regulations and pharma manufacturing’s unique requirements. ISPE elieves moving to Pharma 4.0 Technologies represents a competitive advantage to the extent that not embracing its potential might be a business risk. […]
